Literature DB >> 32408276

Scatter imaging during lung stereotactic body radiation therapy characterized with phantom studies.

Kevin C Jones1, Julius Turian, Gage Redler, Gizem Cifter, John Strologas, Alistair Templeton, Damian Bernard, James C H Chu.   

Abstract

By collecting photons scattered out of the therapy beam, scatter imaging creates images of the treated volume. Two phantoms were used to assess the possible application of scatter imaging for markerless tracking of lung tumors during stereotactic body radiation therapy (SBRT) treatment. A scatter-imaging camera was assembled with a CsI flat-panel detector and a 5 mm diameter pinhole collimator. Scatter images were collected during the irradiation of phantoms with megavoltage photons. To assess scatter image quality, spherical phantom lung tumors of 2.1-2.8 cm diameters were placed inside a static, anthropomorphic phantom. To show the efficacy of the technique with a moving target (3 cm diameter), the position of a simulated tumor was tracked in scatter images during sinusoidal motion (15 mm amplitude, 0.25 Hz frequency) in a dynamic lung phantom in open-field, dynamic conformal arc (DCA), and volumetric modulated arc therapy (VMAT) deliveries. Anatomical features are identifiable on static phantom scatter images collected with 10 MU of delivered dose (2.1 cm diameter lung tumor contrast-to-noise ratio of 4.4). The contrast-to-noise ratio increases with tumor size and delivered dose. During dynamic motion, the position of the 3.0 cm diameter lung tumor was identified with a root-mean-square error of 0.8, 1.2, and 2.9 mm for open field (0.3 s frame integration), DCA (0.5 s), and VMAT (0.5 s), respectively. Based on phantom studies, scatter imaging is a potential technique for markerless lung tumor tracking during SBRT without additional imaging dose. Quality scatter images may be collected at low, clinically relevant doses (10 MU). Scatter images are capable of sub-millimeter tracking precision, but modulation decreases accuracy.

Entities:  

Mesh:

Year:  2020        PMID: 32408276      PMCID: PMC8341471          DOI: 10.1088/1361-6560/ab9355

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  27 in total

1.  Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy.

Authors:  Anne Richter; Juergen Wilbert; Kurt Baier; Michael Flentje; Matthias Guckenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.

Authors:  Juergen Wilbert; Kurt Baier; Christian Hermann; Michael Flentje; Matthias Guckenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

3.  Quantifying the accuracy and precision of a novel real-time 6 degree-of-freedom kilovoltage intrafraction monitoring (KIM) target tracking system.

Authors:  J-H Kim; D T Nguyen; C-Y Huang; T Fuangrod; V Caillet; R O'Brien; P Poulsen; J Booth; P Keall
Journal:  Phys Med Biol       Date:  2017-06-23       Impact factor: 3.609

4.  Evaluation of a template-based algorithm for markerless lung tumour localization on single- and dual-energy kilovoltage images.

Authors:  Alec M Block; Rakesh Patel; Murat Surucu; Matthew M Harkenrider; John C Roeske
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

5.  Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam accelerator.

Authors:  Rune Hansen; Thomas Ravkilde; Esben Schjødt Worm; Jakob Toftegaard; Cai Grau; Kristijan Macek; Per Rugaard Poulsen
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

6.  Directional scatter imaging for the stereoscopic tracking of fiducial markers in a single kV exposure.

Authors:  Héctor Mauricio Garnica-Garza
Journal:  Med Phys       Date:  2017-12-21       Impact factor: 4.071

7.  Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.

Authors:  Shervin M Shirvani; Jing Jiang; Joe Y Chang; James W Welsh; Daniel R Gomez; Stephen Swisher; Thomas A Buchholz; Benjamin D Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-11       Impact factor: 7.038

8.  Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.

Authors:  Houda Bahig; Marie-Pierre Campeau; Toni Vu; Robert Doucet; Dominic Béliveau Nadeau; Bernard Fortin; David Roberge; Louise Lambert; Jean-François Carrier; Edith Filion
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-14       Impact factor: 7.038

9.  MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.

Authors:  Vincent Caillet; Paul J Keall; Emma Colvill; Nicholas Hardcastle; Ricky O'Brien; Kathryn Szymura; Jeremy T Booth
Journal:  Radiother Oncol       Date:  2017-06-24       Impact factor: 6.280

10.  A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Authors:  Gregory M M Videtic; Chen Hu; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Steven E Schild; Ritsuko Komaki; James J Urbanic; Robert D Timmerman; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-17       Impact factor: 7.038

View more
  1 in total

1.  Experimental and numerical studies on kV scattered x-ray imaging for real-time image guidance in radiation therapy.

Authors:  Yanqi Huang; Kai Yang; Youfang Lai; Huan Liu; Chenyang Shen; Yuncheng Zhong; Yiping Shao; Xinhua Li; Bob Liu; Xun Jia
Journal:  Phys Med Biol       Date:  2021-02-11       Impact factor: 3.609

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.